{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:31:00Z","timestamp":1788481860321,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178266","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T06:42:05Z","timestamp":1760683325000},"page":"178266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Amlexanox alleviates renal inflammation and fibrosis by inhibiting cGAS\/STING\/TBK1 and TGF-\u03b21\/Smad signaling"],"prefix":"10.1016","volume":"1007","author":[{"given":"Shobhit","family":"Gairola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8519-274X","authenticated-orcid":false,"given":"Ravinder K.","family":"Kaundal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178266_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41581-025-00934-5","article-title":"Advances and challenges in kidney fibrosis therapeutics","volume":"21","author":"Abbad","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2025.178266_bib2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41401-022-01026-x","article-title":"Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting beta-catenin K49 deacetylation","volume":"44","author":"Chen","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2025.178266_bib3","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/j.ymthe.2022.06.019","article-title":"P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition","volume":"30","author":"Chen","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2025.178266_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","article-title":"Central role of dysregulation of TGF-beta\/Smad in CKD progression and potential targets of its treatment","volume":"101","author":"Chen","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178266_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.987979","article-title":"Crosstalk between TBK1\/IKKepsilon and the type I interferon pathway contributes to tubulointerstitial inflammation and kidney tubular injury","volume":"13","author":"Cordoba-David","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178266_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120845","article-title":"The modulatory effect of sodium molybdate against cisplatin-induced CKD: role of TGF-beta\/Smad signaling pathway","volume":"306","author":"El-Waseif","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.178266_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2025.178266_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174479","article-title":"Nootkatone confers antifibrotic effect by regulating the TGF-beta\/Smad signaling pathway in mouse model of unilateral ureteral obstruction","volume":"910","author":"Gairola","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178266_bib9","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/ptr.8460","article-title":"Exploring the therapeutic potential and underlying mechanism of bergapten in renal fibrosis: network pharmacology, molecular docking, and experimental validation","volume":"39","author":"Gairola","year":"2025","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2025.178266_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118766","article-title":"Amlexanox exerts anti-inflammatory actions by targeting phosphodiesterase 4B in lipopolysaccharide-activated macrophages","volume":"1867","author":"Han","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2025.178266_bib11","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/bph.17412","article-title":"Genetic deficiency or pharmacological inhibition of cGAS-STING signalling suppresses kidney inflammation and fibrosis","volume":"182","author":"Jiao","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178266_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","article-title":"Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.178266_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178155","article-title":"The cGAS-STING axis in kidney disease: mechanisms and therapeutic potential","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178266_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","article-title":"The fibrogenic niche in kidney fibrosis: components and mechanisms","volume":"18","author":"Li","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2025.178266_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12964-024-01723-6","article-title":"Targeting TANK-binding kinase 1 attenuates painful diabetic neuropathy via inhibiting microglia pyroptosis","volume":"22","author":"Liao","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2025.178266_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.celrep.2019.09.050","article-title":"Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury","volume":"29","author":"Maekawa","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.178266_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejphar.2025.178266_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/adt.2019.937","article-title":"Drug repurposing patent applications October-December 2018","volume":"17","author":"Mucke","year":"2019","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejphar.2025.178266_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2025.178266_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2017.06.006","article-title":"Inhibition of IKKvarepsilon and TBK1 improves glucose control in a subset of patients with type 2 diabetes","volume":"26","author":"Oral","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.178266_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0240-4","article-title":"Blocking TBK1 alleviated radiation-induced pulmonary fibrosis and epithelial-mesenchymal transition through Akt-Erk inactivation","volume":"51","author":"Qu","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.178266_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120527","article-title":"Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-beta1\/Smad2\/3 and NF-kB\/NLRP3 signaling axis in mice","volume":"298","author":"Ram","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.178266_bib23","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1039\/D2FO01384C","article-title":"Carvacrol preserves antioxidant status and attenuates kidney fibrosis via modulation of TGF-beta1\/Smad signaling and inflammation","volume":"13","author":"Ram","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2025.178266_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.3082","article-title":"An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice","volume":"19","author":"Reilly","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.178266_bib25","article-title":"The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis","volume":"14","author":"Ren","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178266_bib26","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.2147\/DDDT.S86748","article-title":"CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner","volume":"9","author":"Ren","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2025.178266_bib27","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.ekir.2021.04.023","article-title":"Chronic inflammation in chronic kidney disease progression: role of Nrf2","volume":"6","author":"Stenvinkel","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ejphar.2025.178266_bib28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/art.41152","article-title":"GRK5 inhibition attenuates cartilage degradation via decreased NF-kappaB signaling","volume":"72","author":"Sueishi","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejphar.2025.178266_bib29","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/ndt\/gfad114","article-title":"A single administration of FGF2 after renal ischemia-reperfusion injury alleviates post-injury interstitial fibrosis","volume":"38","author":"Tan","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2025.178266_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41420-024-02087-z","article-title":"Inhibition of PKC-delta retards kidney fibrosis via inhibiting cGAS-STING signaling pathway in mice","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2025.178266_bib31","article-title":"The effects of cGAS-STING inhibition in liver disease, kidney disease, and cellular senescence","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178266_bib32","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.drudis.2021.05.016","article-title":"TANK-binding kinase 1 (TBK1): an emerging therapeutic target for drug discovery","volume":"26","author":"Xiang","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2025.178266_bib33","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/HYPERTENSIONAHA.122.18657","article-title":"Ang II (Angiotensin II)-induced FGFR1 (fibroblast growth factor receptor 1) activation in tubular epithelial cells promotes hypertensive kidney fibrosis and injury","volume":"79","author":"Xu","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2025.178266_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178266_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105145","article-title":"cGAS-STING activation contributes to podocyte injury in diabetic kidney disease","volume":"25","author":"Zang","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ejphar.2025.178266_bib36","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/jcmm.14817","article-title":"Dual TBK1\/IKKvarepsilon inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice","volume":"24","author":"Zhou","year":"2020","journal-title":"J. Cell Mol. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:35:52Z","timestamp":1779323752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925010209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":36,"alternative-id":["S0014299925010209"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178266","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amlexanox alleviates renal inflammation and fibrosis by inhibiting cGAS\/STING\/TBK1 and TGF-\u03b21\/Smad signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178266"}}